These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16846532)

  • 21. Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review.
    Lavasani MA; Moinfar F
    J Biophotonics; 2012 Apr; 5(4):345-66. PubMed ID: 22232077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
    Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F
    Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change?
    Raica M; Jung I; Cîmpean AM; Suciu C; Mureşan AM
    Rom J Morphol Embryol; 2009; 50(1):5-13. PubMed ID: 19221640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
    Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
    Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
    Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
    Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and validation of breast cancer subtypes.
    Kapp AV; Jeffrey SS; Langerød A; Børresen-Dale AL; Han W; Noh DY; Bukholm IR; Nicolau M; Brown PO; Tibshirani R
    BMC Genomics; 2006 Sep; 7():231. PubMed ID: 16965636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population.
    Han W; Nicolau M; Noh DY; Jeffrey SS
    Int J Oncol; 2010 Jul; 37(1):51-9. PubMed ID: 20514396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
    Pawitan Y; Bjöhle J; Amler L; Borg AL; Egyhazi S; Hall P; Han X; Holmberg L; Huang F; Klaar S; Liu ET; Miller L; Nordgren H; Ploner A; Sandelin K; Shaw PM; Smeds J; Skoog L; Wedrén S; Bergh J
    Breast Cancer Res; 2005; 7(6):R953-64. PubMed ID: 16280042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile?
    Nicolini A; Ferrari P; Fallahi P; Antonelli A
    Future Oncol; 2012 Feb; 8(2):131-4. PubMed ID: 22335577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hopes and pitfalls of the molecular classification of breast cancer].
    Ryška A; Hovorková E; Sobande F; Rozkoš T; Laco J; Hornychová H
    Cesk Patol; 2015; 51(1):26-32. PubMed ID: 25671359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.
    Habermann JK; Doering J; Hautaniemi S; Roblick UJ; Bündgen NK; Nicorici D; Kronenwett U; Rathnagiriswaran S; Mettu RK; Ma Y; Krüger S; Bruch HP; Auer G; Guo NL; Ried T
    Int J Cancer; 2009 Apr; 124(7):1552-64. PubMed ID: 19101988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures.
    Coleman WB; Anders CK
    Am J Pathol; 2017 Oct; 187(10):2199-2207. PubMed ID: 28822803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on clinical trials: genetic targets in breast cancer.
    Lim B; Cream LV; Harvey HA
    Adv Exp Med Biol; 2013; 779():35-54. PubMed ID: 23288634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival outcomes are associated with genomic instability in luminal breast cancers.
    King L; Flaus A; Holian E; Golden A
    PLoS One; 2021; 16(2):e0245042. PubMed ID: 33534788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.
    Russnes HG; Lingjærde OC; Børresen-Dale AL; Caldas C
    Am J Pathol; 2017 Oct; 187(10):2152-2162. PubMed ID: 28733194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deconstructing the molecular portraits of breast cancer.
    Prat A; Perou CM
    Mol Oncol; 2011 Feb; 5(1):5-23. PubMed ID: 21147047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Expression Meta-Analysis Identifies Cytokine Pathways and 5q Aberrations Involved in Metastasis of ERBB2 Amplified and Basal Breast Cancer.
    Thomassen M; Tan Q; Burton M; Kruse TA
    Cancer Inform; 2013; 12():203-19. PubMed ID: 24327800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.